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cardiac ﬁbroblasts induced by TGF-b1. DIM attenuated theincreased
phosphorylation of AKT and GSK-3b induced by TGF-b1.
CONCLUSIONS Our results showed that DIM was a potential drug to
attenuate myoﬁbroblast differentiation and modulate the excessive
ECM production induced by TGF-b1 through down-regulated AKT/
GSK-3b signaling pathways.
GW26-e4573
Anti-inﬂammatory effect of 3,30-Diindolylmethane on LPS-induced
inﬂammatory injury in neonatal rat cardiac myocytes via suppressing
TLR-4/MAPKs signaling pathways
Jin Li, Qingqing Wu, Wei Deng, Qizhu Tang
Department of cardiology, Renmin Hospital of Wuhan university
OBJECTIVES 3, 3’-Diindolylmethane (DIM), extracted from crucif-
erous plants, has been shown to possess anti-inﬂammatory properties
in various models of inﬂammatory diseases. However, whether DIM
has an anti-inﬂammatory effect onlipopolysaccharide (LPS)-induced
neonatal rat cardiac myocytes injury is poorly understood. Therefore,
this study aimed to evaluate the effects of DIM on LPS-induced in-
ﬂammatory injury in neonatal rat cardiomyocytes and explore the
anti-inﬂammatory molecular mechanisms.
METHODS The cultured neonatal rat cardiomyocytes in vitro were
stimulated with LPS (10 mg/L) for 12 h or 24 h to induce inﬂammatory
injury, and DIM was incubated with these cells in the presence and
absence of LPS. Cell viability was measured by CCK8, the morphology
of cultured neonatal cardiomyocytes was observed with immunoﬂu-
orescence staining. The mRNA expression levels of inﬂammatory
mediators were measured with Real-time PCR and theprotein
expression levels were examined with Western Blotting analysis.
RESULTS Our data showed that DIM could obviously attenuate the
increased mRNA expression levels of pro-inﬂammatory cytokines
including interleukin (IL)-6, tumor necrosis factor (TNF)-a and high
mobility group box 1 (HMGB1) induced by LPS. Moreover, DIM could
also remarkably inhibit the elevated protein expression levels of Toll
like receptor-4 (TLR-4), phosphorylated extracellular signal-regulated
kinases 1/2 (ERK1/2), phosphorylated P38 and phosphorylated
c-Jun NH2 - terminal kinase (JNK) induced by LPS.
CONCLUSIONS Our results suggested that DIM had a protective effect
on LPS-induced inﬂammatory injury in neonatal rat cardiomyocytes,
and modulated the excessive production of pro-inﬂammatory cyto-
kines IL-6, TNF-a and HMGB1 via suppressing the TLR-4 / MAPKs
signaling pathways.
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IL-24 gene protects against H2O2-mediated injury of human umbilical vein
endothelial cells and may be useful as a treatment for cardiovascular
disease
Zhaoxia Wang,1 Yang Wang,2 Jiyuan Lv1
1First Hospital of Shanxi Medical University, Taiyuan, Shanxi, P.R.
China; 2Bank of China Shanxi Branch, Taiyuan, Shanxi, P.R. China
OBJECTIVES To investigate the protective effect of IL-24 on H2O2-
induced vascular endothelial injury and to examine the association
between IL-24 and cardiovascular disease.
METHODS Human umbilical vein endothelial cells (HUVECs) were
treated with increasing concentrations of H2O2 in the presence or
absence of IL-24, which was introduced via Lipofectamine 2000-
mediated transfection. Successful uptake of IL-24 plasmid was
conﬁrmed by RT-PCR 24 hours post-transfection. The effect of H2O2
and IL-24 on HUVEC proliferation and migration was determined by
migration assays. Cell viability was determined by CCK-8. Apoptosis
and measurement of intracellular ROS levels were determined by ﬂow
cytometry. Real-time PCR and Western blot were used to detect levels
of multiple cardiovascular disease-associated factors. Experiments
were also performed in a rat hypertension model. RNA and protein
levels of IL-24 were measured in both control and hypertensive rats;
the effects of enalapril and nifedipine treatments on IL-24 levels were
also examined.
RESULTS IL-24 protects against the H2O2 - mediated abnormal in-
crease in HUVEC cell proliferation. IL-24 also antagonizes H2O2 by
reducing the content of ROS in cells, decreasing cellular oxidative
damage, improving cellular survival rate, reducing apoptosis, and
decreasing expression of cardiovascular disease-related factors. Invivo animal experiments showed that IL-24 expression was lower in
hypertensive rats compared to healthy controls. Additionally, IL-24
levels increased following anti-hypertension therapy.
CONCLUSIONS IL-24 protects against H2O2 - mediated endothelial
cell damage and might provide new beneﬁts for the treatment of
cardiovascular disease.GW26-e4589
C1q/Tumor Necrosis Factor-Related Protein-9, a Novel Adipocyte-Derived
Cytokine, suppresses high glucose-induced proliferation and collagen
synthesis in rat cardiac ﬁbroblasts
Yongjun Li
The Second Hospital of Hebei Medical University
OBJECTIVES C1q/TNF-related protein (CTRP) 9 is an adipocytokine
that is downregulated in obese mice. The objectives of the present
study were to determine the effects of CTRP9 on high glucose
(HG)-induced proliferation and collagen production in rat cardiac
ﬁbroblasts (CFs) and to investigate the molecular mechanism
involved.
METHODS Rat CFs were cultured in Dulbecco’s modiﬁed Eagle’s
medium, supplemented with 5.0 or 25 mmol/L D-glucose or
5.0 mmol/L D-glucose þ 19.5 mmol/L mannose, in the presence of
absence of CTRP 9. Proliferation was measured by the MTT assay,
whereas the production of Type I collagen was determined by
ELISA and reverse transcription-polymerase chain reaction. Intra-
cellular Type I procollagen protein levels were evaluated using
immunocytochemistry.
RESULTS CTRP 9 treatment effectively inhibited HG (25 mmol/L D-
glucose)-induced increases in the proliferation of CFs and collagen
synthesis, concomitant with suppression of HG-induced upregulation
of cAMP levels. Blockade of cAMP-PKA pathway reversed the inhibi-
tory effect of CTRP9 on ERK phosphorylation in response to HG.
CONCLUSIONS The present data indicate that CTRP9 functions to
inhibited HG (25 mmol/L D-glucose)-induced increases in the prolif-
eration of CFs and collagen synthesis via cAMP- dependent mecha-
nism, suggesting that the therapeutic approaches to enhance CTRP9
production could be valuable for prevention of diabetes cardiac
ﬁbrosis.
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The effects of AGEs and RAGE on the accelerated progression of age-
related intrarenal small arterial stiffness in hypertensive rats
Yajing Bai,1 Huashan Hong2
1Department of Intensive Care Unit, Fujian Medical University Union
Hospital, Fuzhou, Fujian, China; 2Department of Geriatrics, Fujian
Medical University Union Hospital, Fuzhou, Fujian, China
OBJECTIVES To dynamically investigate the morphological change of
age-related intrarenal small arterial(IRSA) in Spontaneously hyper-
tensive rat (SHR) and Wistar-Kyoto (WKY) rats respectively and to
explore the effects of Advanced glycation end-products (AGEs) and
Receptor for AGEs (RAGE) on the progression of age-related IRSA
stiffness accelerated by hypertension.
METHODS SHR and WKY rats were respectively randomized into 4,
12, 24, 48 and 72-week-old group (n¼16). Minimal renal vascular
resistance (minRVR) was detected at each group. Renal arcuate
arteries (RAA) and interlobular arteries (RILA) were analyzed by EVG,
HE, Sirus-red staining, a-smooth muscle actin (a-SMA) immunoﬂuo-
rescent technique and proliferating cell nuclear antigen (PCNA), AGEs,
RAGE immunohistochemical staining, and various morphological in-
dexes and medial cell proliferation index(PI) were measured. The
concentration of serum AGEs was assessed by ELISA.
RESULTS TheminRVR and themorphological indexs ofmedial nuclear
area, medial collagen area and medial thickness of RAA and RILA had
shown an age-dependent increase since 24w in SHR and 72w in WKY
respectively, accompanied by the increased expression of RAGE in
media. The expressions of AGEs in serum and both IRSA media were
also signiﬁcantly elevated at 72w WKY consistently, while the levels of
AGEs began to increase from 48w in SHR. Interestingly, the collagen
area and the expression of RAGE n RILAmedia at 12w SHR had begun to
be much higher than that in 4w SHR group (p <0.05).
CONCLUSIONS Hypertension accelerates the progression of age-
related intrarenal small arterial stiffness and the hypertension to
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accelerate the age-related RAA stiffness. The mechanism is probably
associated with the up-regulated level of RAGE in IRSA media,
while the AGEs in serum or IRSA media may be involved in the late
stage.GW26-e4656
Polymorphism of RBP4 Locus Is Associated with 5-Year Survival in acute
coronary syndrome after coronary revascularization
Ke Wan, Zhi Zeng
West China Hospital, Sichuan University
OBJECTIVES The rs7094671 was single nucleotide polymorphism of
RBP4 locus that was associated with prevalence of coronary artery
disease. No data concerning their association with long term prog-
nosis after myocardial infarction is available. The aim of our study was
to investigate the association of the RBP4 locus with 5-year overall
mortality in patients with acute coronary syndrome after coronary
revascularization.
METHODS Cohort study included 292 patients with acute coronary
syndrome treated with primary PCI, followed for up to 5 years. Gen-
otyping was performed with high resolution melting (HRM) analysis.
The analyzed end-point was total 5-year mortality.
RESULTS The baseline characteristics were well-balanced between
carriers (AA, n ¼ 19; AG, n ¼ 73) and GG (n ¼ 200) of the RBP4
variant. During the follow-up period (52.4511.98months), the pri-
mary endpoint occurred more frequently in carriers of A allele than
in non-carriers of A allele (24.8% versus 9.3%; hazard ratio [HR] ¼
2.656; 95% conﬁdence interval [CI] ¼ 1.642–4.295; P ¼ 0.000);
Kaplan–Meier estimation of the primary outcome measure (death of
any cause) during the follow-up period. (AA groups versus GG
groups: adjusted HR ¼ 6.321, 95% CI 2.081–19.205, P ¼ 0.001), GA
groups versus GG groups: adjusted HR ¼ 1.303, 95% CI ¼ 0.478–
3.548, P ¼ 0.605).
CONCLUSIONS The RBP4 locus is associated with 5-year mortality in
high-risk patients with acute coronary syndrome.GW26-e4667
Effect of Oxidatively Modiﬁed Low-Density Lipoprotein on
Osteodifferentiation of Mesenchymal Stem Cells Co-cultured with
Vascular Smooth Muscle Cells
Xiaochun Chen, C.H.E.N. Xiaochun, Hou Yu, Li Xiuling, Li Hanqing
Department of cardiology, International Mongolia Hospital of Inner
Mongolia, Hohhot 010065, Inner Mongolia, China
OBJECTIVES Increasing evidences revealed that bone marrow-
derived mesenchymal stem cells (BM-MSCs) played important role in
wound healing and vascular remodeling in vivo. However, the
mechanism in the development of atherosclerosis and vessel calcify
remains unclear. The aim of this study was to investigate the effect
of oxidatively modiﬁed low-density lipoprotein (ox-LDL) on osteo-
diferenliation of BM-MSCs co-cultured with smooth muscle cells
with or without osteogenic inductor, and further to explore the
mechanism of BM-MSCs participating in atherosclerosis and vessel
calcify.
METHODS BM-MSCs and vascular smooth muscle cells (VSMCs) were
prepared from Sprague-Dawley rats and co-cultured in a transwell
coculture system, which allowed the diffusion of secreted factors but
prevented cell contact. Thecombined group (both osteogenic inductor
and ox-LDL), ox-LDL group, osteogenic inductor group and control
group were allocated according to factorial design method. The effect
of ox-LDL on the osteogenic potential was determined by cell
morphology, real-time PCR, immunoﬂuorescent staining, alkaline
phosphatase (AKP) activity and osteopontin (OPN) synthesis.
RESULTS 1. All groups expressed OPN mRNA and AKP and but the
OPN mRNA and AKP expression levels of combined group were
the highest after 7 days and 10 days of cell culture, moreover, there
was positive interaction between osteogenic inductor and ox-LDL
(P <0.01).
2. The result of immunity histochemistry also showed that OPN and
AKP expression levels in combined group were the highest after 14
days of cell culture.
CONCLUSIONS Ox-LDL can promote osteogenic inductor-mediated
osteodifferentiation of BM-MSCs co-cultured with smooth muscle
cells.GW26-e4724
The role of mAKAPb in the process of cardiomyocyte hypertrophy induced
by angiotensin II
Huixin Guo, Baoxin Liu, Yidong Wei
Department of Cardiology, Shanghai Tenth People’s Hospital, Tongji
University School of Medicine
OBJECTIVES Angiotensin II (AngII) is the central product of the
reninangiotensin system (RAS) and this octapeptide contributes to
the pathophysiology of cardiac hypertrophy and remodeling.
mAKAPb is an Akinase anchoring protein (AKAP) that has the func-
tion of binding to the regulatory subunit of protein kinase A (PKA)
and conﬁning the holoenzyme to discrete locations within the cell.
In this study, we aimed to investigate the role of mAKAPb in AngII
induced cardiomyocyte hypertrophy and the possible mechanisms
involved.
METHODS Cultured cardiomyocytes from neonatal rats were treated
with AngII. Subsequently, the morphology of the cardiomyocytes was
observed and the expression of mAKAPb and cardiomyocyte hyper-
trophic markers was measured. mAKAPb–shRNA was constructed for
RNA interference; the expression of mAKAPb and hypertrophic
markers, the cell surface area and the [3H] Leucine incorporation rate
in the AngII–treated rat cardiomyocytes were detected following RNA
interference. Simultaneously, changes in the expression levels of
phosphorylated extracellular signal–regulated kinase (p-ERK)2 in the
cardiomyocytes were assessed.
RESULTS The cell size of the AngII - treated cardiaomyocytes was
signiﬁcantly larger than that of the untreated cardiomyocytes. The
expression of hypertrophic markers and p-ERK2, the cell surface area
and the [3H] Leucine incorporation rate were all signiﬁcantly
increased in the AngII - treated cells. However, the expression of
mAKAPb remained unaltered in this process. RNA interference
simultaneously inhibited the protein expression of mAKAPb and
p–ERK2, and the hypertrophy of the cardiomyocytes induced by AngII
was attenuated.
CONCLUSIONS AngII induces hypertrophy in cardiomyocytes and
mAKAPb is possibly involved in this process. The effects of mAKAPb
on AngII–induced cardiomyocyte hypertrophy may be associated with
p–ERK2 expression.GW26-e4732
The Effect Of Catecholamine Release-Inhibitory Peptide Catestatin On
Heart Rate And Blood Pressure Of Hypertension
Jianqiang Guo, Sujuan Li, Yafang Yi
The Afﬁliated Hospital of Inner Mongolia Medical University
OBJECTIVES The catecholamine release-inhibitory peptide cate-
statin is an endogenous nicotinic cholinergic antagonist that can
inhibit secretion of catecholamine from chromafﬁn cells and
adrenergic neurons. Therefore it can inhibit sympathetic nerve ac-
tivity. Previous studies have shown that catestatin have a close
relationship with the occurrence and development of hypertension
and that catestatin is diminished in established hypertension.
This study focus on the effect of catestatin on heart rate and
blood pressure of hypertension by supplementing spontaneously
hypertensive rats (spontaneously hypertensive rats, SHR) with
catestatin.
METHODS We used SHR as a hypertensive model and matched it
with the homologous normotensive rats (wistar-Kyoto, WKY) as
normal control group. Blood pressure and heart rate were obtained
from the measurement tail-cuff blood pressure. First, we observed
the difference of blood pressure and heart rate between SHR and
WKY at the age of 6, 12 and 16 weeks. Second, twelve-week-old SHR
were treated with 1mg catestatin via the tail vein injection. Thirty
minutes after injection, heart rate and blood pressure were
measured to observe its short-term effects on blood pressure and
heart rate. Furthermore, we also treated twelve-week-old SHR with
catestatin for 5 weeks (tail vein injection for three times a week,
each 1mg) to observe its long-term effects on blood pressure and
heart rate. Each group has 5 rats.
RESULTS First, the blood pressure and heart rate of SHR were
signiﬁcantly higher than that of WKY at corresponding ages. SHR VS
WKY, six-week-old: heart rate (41828 VS 36624 (beats/min),
P<0.05), blood pressure (1489/1086 VS 11811/859mmHg,
P<0.05); twelve-week-old: heart rate (39730 VS 32625 (beats/min),
P<0.05); blood pressure (19315/15512 VS 1237/9110 mmHg,
